CTRI/2023/07/055869尚未招募Unknown
CLINICO-EPIDEMIOLOGICAL PROFILE AND PREDICTORS OF MORTALITY IN ACUTE ENCEPHALITIS SYNDROME IN CHILDREN - NI
K Rajeshwari0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •All children between 1 month to 12 years getting hospitalized with Acute Encephalitis Syndrome (AES) as per WHO clinical case definition:
- •1. Children between ages 1 month to 12 years with the acute onset of fever.
- •2. Fever should be associated with change in mental status such as confusion, disorientation, coma or inability to talk.
- •3. And/Or new onset of seizures.
排除标准
- •1. Children who are known cases of epilepsy.
- •2. Children with previously diagnosed metabolic/genetic disorders.
- •3. Children who are known cases of febrile seizures.
- •4. Patients leaving against medical advice (LAMA)/ discharge on request/ absconding.
研究者
相似试验
招募中
不适用
Description of the clinical characteristics of patients with inflammatory bowel diseases in public hospitals at northeastern BrazilCrohn DiseaseRBR-6wkrrdInstituto Autoimune
尚未招募
不适用
Outcome of Tuberculosis of the nervous system in childreCTRI/2019/05/019218Maulana Azad Medical College
尚未招募
Unknown
A clinical trial to determine the risk factors and angiographic profile of young patients with acute coronary syndromeCTRI/2024/06/069052Dr Hargun Arneja
已完成
不适用
Clinical Outcomes and Prognostic Factors to Predict Treatment Response in High Risk Neuroblastoma Patients Receiving Topotecan and Cyclophosphamide Containing Induction Regimen: A Prospective Multicenter StudyThe study is an observational study and aims to evaluate the clinical outcomes and classify relevant prognostic factors to measure induction response among high risk neuroblastoma patients in Thailandhigh risked neuroblastoma,topotecan,induction therapy,treatment response,prognostic factor,treatment-related toxicityTCTR20190602002Phramongkutklao Hospital and College of Medicine107
招募中
不适用
Epidemiology and clinical characteristics - based Rome III and IV criteria in Japanese FD patients: a multicenter prospective observational studyJPRN-UMIN000041094Hyogo College of Medicine200